
Global RNA Interference (RNAi) Drug Delivery Market Research Report 2021
- QYResearch
- January 2021
- Medical Equipments
- 123 pages
Report Description
Segment by Type
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology
Segment by Application
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc
Product Type & Applications
- Metabolic disorders
- Alnylam Pharmaceuticals Inc
- Merck & Co. Inc
- Access Pharmaceuticals Inc
- Dicerna Pharmaceuticals Inc
- Calondo Pharmaceuticals Inc
- Marina Biotech Inc
- RXi Pharmaceuticals Corp
- Quark Pharmaceuticals Inc
- Silence Therapeutics plc
- Tacere Therapeutics Inc
- PhaseRx Inc
-
RNA Interference (RNAi) Drug Delivery
-
Infectious Diseases
-
Cardiology
-
Oncology
-
Neurology
-
Ophthalmology
-
Metabolic Disorders
Have query on this report?
Make an Enquiry
1 RNA Interference (RNAi) Drug Delivery Market Overview
1.1 Product Overview and Scope of RNA Interference (RNAi) Drug Delivery
1.2 RNA Interference (RNAi) Drug Delivery Segment by Type
1.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nanoparticle Drug Delivery Technology
1.1 Product Overview and Scope of RNA Interference (RNAi) Drug Delivery
1.2 RNA Interference (RNAi) Drug Delivery Segment by Type
1.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nanoparticle Drug Delivery Technology
List of Tables
Table 1. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global RNA Interference (RNAi) Drug Delivery Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers RNA Interference (RNAi) Drug Delivery Covered in This Study
Table 5. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) of Key Manufacturers (2016-2021)
Table 1. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global RNA Interference (RNAi) Drug Delivery Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers RNA Interference (RNAi) Drug Delivery Covered in This Study
Table 5. Global RNA Interference (RNAi) Drug Delivery Sales (K Units) of Key Manufacturers (2016-2021)
Success Stories
Our Clients






More from Medical Equipments
